ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
UK Regulatory Authorisation to Proceed with Phase 2 Trial
Published: 27/04/22, 12:06pm (AEST)•3 pages